Criminal fine for J & J drug company re Risperdal anti-psychotic

"Johnson & Johnson has agreed to pay as much as $2.2 billion to resolve an investigation into its marketing of the anti-psychotic drug Risperdal, according to a published report."
Read article in the Houston Chronicle (USA)